General Meeting Results

Summary by AI ^BETAClose X

Caspian Sunrise plc announced that at its General Meeting on January 30, 2026, shareholders overwhelmingly approved the audited accounts for the year ended December 31, 2024, with 99.95% of proxy votes in favour, and the Remuneration Committee report with 99.84% of proxy votes in favour. The resolutions to receive the Directors' and Auditors' reports were also approved with a substantial majority.

Disclaimer*

Caspian Sunrise plc

02 February 2026

Caspian Sunrise PLC

General Meeting Results

The Caspian Sunrise board is pleased to report that at the General Meeting held on 30 January 2026 the resolutions to receive the audited accounts for the year ended 31 December 2024 and the reports of the Directors and Auditors and to approve the Remuneration Committee report contained therein were approved with the following majorities:

Resolution		Proxy votes for		Proxy votes against
		Number	%	Number	%
1	To receive the accounts for the Company for the year ended 31 December 2024 and the reports of the Directors and Auditors	1,289,849,911	99.95	584,184	0.05

2	To approve the Remuneration Committee report for the year ended 31 December 2024	1,288,127,025	99.84	2,041,402	0.16

Contacts:

Caspian Sunrise PLC

Clive Carver, Chairman +7 727 375 0202

Zeus, Nominated Adviser & Broker

James Joyce +44 (0) 203 829 5000

James Bavister

Andrew de Andrade

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END